Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Florbetapir F18 PET Imaging in Parkinson's Disease
NCT00857532Phase 2Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Jan 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Florbetapir in Parkinson's disease (PD), sponsored by Avid Radiopharmaceuticals. Started Jan 2009; status: completed.
02
Drugs
Florbetapir
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00857532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857532.